首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current cardiovascular risk reports

缩写:

ISSN:1932-9520

e-ISSN:1932-9563

IF/分区:1.8/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引140
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kelsey Ufholz,Daksh Bhargava Kelsey Ufholz
Purpose of review: Telemedicine has become popular as an alternative for in-person weight loss treatment during the COVID-19 pandemic. This review focuses on weight loss interventions utilizing real-time telemedicine. ...
Melissa K Thomas,Lori J Lammert,Elizabeth A Beverly Melissa K Thomas
Purpose of review: Food insecurity (FI) is a serious public health issue affecting 2 billion people worldwide. FI is associated with increased risk for multiple chronic diseases, including obesity, type 2 diabetes, cardio...
Pishoy Gouda,Elie Ganni,Peter Chung et al. Pishoy Gouda et al.
Purpose of review: With the rising cost of cardiovascular clinical trials, there is interest in determining whether new technologies can increase cost effectiveness. This review focuses on current and potential uses of vo...
Allison J Hare,Neel Chokshi,Srinath Adusumalli Allison J Hare
Purpose of review: Hypertension is common, impacting an estimated 108 million US adults, and deadly, responsible for the deaths of one in six adults annually. Optimal management includes frequent blood pressure monitoring...
Minhal Makshood,Wendy S Post,Alka M Kanaya Minhal Makshood
Purpose of review: This review focuses on lipoprotein abnormalities in South Asians (SA) and addresses risk stratification and management strategies to lower atherosclerotic cardiovascular disease (ASCVD) in this high-ris...
Jennalyn D Mayeux,Irene Z Pan,John Dechand et al. Jennalyn D Mayeux et al.
Purpose of review: This review focuses on the therapeutic management and individualized approach to Group 1 pulmonary arterial hypertension (PAH), utilizing Food and Drug Administration-approved PAH-specific therapies and...
Connor Tice,Matthew Seigerman,Paul Fiorilli et al. Connor Tice et al.
Purpose of the review: Over 100,000 cardiovascular-related deaths annually are caused by acute pulmonary embolism (PE). While anticoagulation has historically been the foundation for treatment of PE, this review highlight...
Anandita Agarwala,Jing Liu,Christie M Ballantyne et al. Anandita Agarwala et al.
Purpose of review: In 2018, the AHA/ACC multi-society Cholesterol Guidelines introduced the novel concept of risk-enhancing factors to be used as a supplement to the pooled cohort risk equations to personalize atheroscler...
Kosuke Tamura,Steven D Langerman,Joniqua N Ceasar et al. Kosuke Tamura et al.
Purpose of review: Limited physical activity (PA) and obesity are two primary risk factors for cardiovascular disease (CVD). Within a socio-ecological framework, neighborhood social environment may play a key role in infl...
Jessica K Zègre-Hemsey,Brittany Bogle,Christopher J Cunningham et al. Jessica K Zègre-Hemsey et al.
Purpose of review: Out-of-hospital cardiac arrest (OHCA) remains a significant health problem in the USA and only 8.6% of victims survive with good neurological function, despite advances in emergency cardiac care. The li...